Global Pharmaceutical Contract Manufacturing Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	164 Pages	TechNavio	August, 2024	INF19179023

Best Price Guarantee
Price	from $2,500
Length	164 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19179023

Global Pharmaceutical Contract Manufacturing Market 2024-2028

Pharmaceutical Contract Manufacturing Market 2024-2028

The pharmaceutical contract manufacturing market is forecasted to grow by USD 64.8 bn during 2023-2028, accelerating at a CAGR of 8.1% during the forecast period. The report on the pharmaceutical contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by patent expiry and increasing demand for generic drugs, growing need to focus on core competencies, and strong research funding.

Technavio's pharmaceutical contract manufacturing market is segmented as below:

By End-user

Big pharmaceutical companies
Small and medium-sized pharmaceutical companies
Generic pharmaceutical companies

By Service

API/bulk drug manufacturing
Final dosage form
Secondary packaging

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the increasing number of US fda-approved manufacturing facilities as one of the prime reasons driving the pharmaceutical contract manufacturing market growth during the next few years. Also, rising demand for biological therapies and advent of big data will lead to sizable demand in the market.

The report on the pharmaceutical contract manufacturing market covers the following areas:

Pharmaceutical contract manufacturing market sizing
Pharmaceutical contract manufacturing market forecast
Pharmaceutical contract manufacturing market industry analysis

The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical contract manufacturing market vendors that include AbbVie Inc., Almac Group Ltd., Baxter International Inc., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Charles River Laboratories International Inc., Cmic Holdings Co. Ltd, Dalton Pharma Services, DR Reddys Laboratories Ltd., Grifols SA, Laboratory Corp. of America Holdings, Lonza Group Ltd., Lupin Ltd., Novotech Health Holdings, OPTIMAPHARM d.o.o., Parexel International Corp., PCI Pharma Services, Recipharm AB, Syneos Health Inc., and Thermo Fisher Scientific Inc.. Also, the pharmaceutical contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Service; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ billion); Data Table on Global - Market size and forecast 2023-2028 ($ billion); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Pharmaceutical Contract Manufacturing Market 2018 - 2022; Historic Market Size - Data Table on Global Pharmaceutical Contract Manufacturing Market 2018 - 2022 ($ billion); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ billion); 4.3 Service segment analysis 2018 - 2022; Historic Market Size - Service Segment 2018 - 2022 ($ billion); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Big pharmaceutical companies - Market size and forecast 2023-2028; Chart on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Data Table on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Chart on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%); Data Table on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%); 6.4 Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028; Chart on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Data Table on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Chart on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%); Data Table on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%); 6.5 Generic pharmaceutical companies - Market size and forecast 2023-2028; Chart on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Data Table on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Chart on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%); Data Table on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Market opportunity by End-user ($ billion); Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Service: 7.1 Market segments; Chart on Service - Market share 2023-2028 (%); Data Table on Service - Market share 2023-2028 (%); 7.2 Comparison by Service; Chart on Comparison by Service; Data Table on Comparison by Service; 7.3 API/bulk drug manufacturing - Market size and forecast 2023-2028; Chart on API/bulk drug manufacturing - Market size and forecast 2023-2028 ($ billion); Data Table on API/bulk drug manufacturing - Market size and forecast 2023-2028 ($ billion); Chart on API/bulk drug manufacturing - Year-over-year growth 2023-2028 (%); Data Table on API/bulk drug manufacturing - Year-over-year growth 2023-2028 (%); 7.4 Final dosage form - Market size and forecast 2023-2028; Chart on Final dosage form - Market size and forecast 2023-2028 ($ billion); Data Table on Final dosage form - Market size and forecast 2023-2028 ($ billion); Chart on Final dosage form - Year-over-year growth 2023-2028 (%); Data Table on Final dosage form - Year-over-year growth 2023-2028 (%); 7.5 Secondary packaging - Market size and forecast 2023-2028; Chart on Secondary packaging - Market size and forecast 2023-2028 ($ billion); Data Table on Secondary packaging - Market size and forecast 2023-2028 ($ billion); Chart on Secondary packaging - Year-over-year growth 2023-2028 (%); Data Table on Secondary packaging - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Service; Market opportunity by Service ($ billion); Data Table on Market opportunity by Service ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ billion); Data Table on North America - Market size and forecast 2023-2028 ($ billion); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ billion); Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.5 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ billion); Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ billion); Data Table on US - Market size and forecast 2023-2028 ($ billion); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ billion); Data Table on China - Market size and forecast 2023-2028 ($ billion); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 India - Market size and forecast 2023-2028; Chart on India - Market size and forecast 2023-2028 ($ billion); Data Table on India - Market size and forecast 2023-2028 ($ billion); Chart on India - Year-over-year growth 2023-2028 (%); Data Table on India - Year-over-year growth 2023-2028 (%); 9.10 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ billion); Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ billion); Data Table on UK - Market size and forecast 2023-2028 ($ billion); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Almac Group Ltd.; Almac Group Ltd. - Overview; Almac Group Ltd. - Product / Service; Almac Group Ltd. - Key offerings; 12.4 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; 12.5 Cadila Pharmaceuticals Ltd.; Cadila Pharmaceuticals Ltd. - Overview; Cadila Pharmaceuticals Ltd. - Product / Service; Cadila Pharmaceuticals Ltd. - Key offerings; 12.6 Charles River Laboratories International Inc.; Charles River Laboratories International Inc. - Overview; Charles River Laboratories International Inc. - Business segments; Charles River Laboratories International Inc. - Key offerings; Charles River Laboratories International Inc. - Segment focus; 12.7 Cmic Holdings Co. Ltd; Cmic Holdings Co. Ltd - Overview; Cmic Holdings Co. Ltd - Business segments; Cmic Holdings Co. Ltd - Key offerings; Cmic Holdings Co. Ltd - Segment focus; 12.8 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; 12.9 Laboratory Corp. of America Holdings; Laboratory Corp. of America Holdings - Overview; Laboratory Corp. of America Holdings - Business segments; Laboratory Corp. of America Holdings - Key news; Laboratory Corp. of America Holdings - Key offerings; Laboratory Corp. of America Holdings - Segment focus; 12.10 Lonza Group Ltd.; Lonza Group Ltd. - Overview; Lonza Group Ltd. - Business segments; Lonza Group Ltd. - Key news; Lonza Group Ltd. - Key offerings; Lonza Group Ltd. - Segment focus; 12.11 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Business segments; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; Lupin Ltd. - Segment focus; 12.12 OPTIMAPHARM d.o.o.; OPTIMAPHARM d.o.o. - Overview; OPTIMAPHARM d.o.o. - Product / Service; OPTIMAPHARM d.o.o. - Key offerings; 12.13 Parexel International Corp.; Parexel International Corp. - Overview; Parexel International Corp. - Product / Service; Parexel International Corp. - Key offerings; 12.14 PCI Pharma Services; PCI Pharma Services - Overview; PCI Pharma Services - Product / Service; PCI Pharma Services - Key offerings; 12.15 Recipharm AB; Recipharm AB - Overview; Recipharm AB - Business segments; Recipharm AB - Key offerings; Recipharm AB - Segment focus; 12.16 Syneos Health Inc.; Syneos Health Inc. - Overview; Syneos Health Inc. - Product / Service; Syneos Health Inc. - Key offerings; 12.17 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Service; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Pharmaceutical Contract Manufacturing Market 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Service Segment 2018 - 2022 ($ billion); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on End-user - Market share 2023-2028 (%); Exhibits33: Data Table on End-user - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by End-user; Exhibits35: Data Table on Comparison by End-user; Exhibits36: Chart on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Exhibits37: Data Table on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Exhibits38: Chart on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Exhibits41: Data Table on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Exhibits42: Chart on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Exhibits45: Data Table on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion); Exhibits46: Chart on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by End-user ($ billion); Exhibits49: Data Table on Market opportunity by End-user ($ billion); Exhibits50: Chart on Service - Market share 2023-2028 (%); Exhibits51: Data Table on Service - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Service; Exhibits53: Data Table on Comparison by Service; Exhibits54: Chart on API/bulk drug manufacturing - Market size and forecast 2023-2028 ($ billion); Exhibits55: Data Table on API/bulk drug manufacturing - Market size and forecast 2023-2028 ($ billion); Exhibits56: Chart on API/bulk drug manufacturing - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on API/bulk drug manufacturing - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Final dosage form - Market size and forecast 2023-2028 ($ billion); Exhibits59: Data Table on Final dosage form - Market size and forecast 2023-2028 ($ billion); Exhibits60: Chart on Final dosage form - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Final dosage form - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Secondary packaging - Market size and forecast 2023-2028 ($ billion); Exhibits63: Data Table on Secondary packaging - Market size and forecast 2023-2028 ($ billion); Exhibits64: Chart on Secondary packaging - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Secondary packaging - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Service ($ billion); Exhibits67: Data Table on Market opportunity by Service ($ billion); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on India - Market size and forecast 2023-2028 ($ billion); Exhibits98: Data Table on India - Market size and forecast 2023-2028 ($ billion); Exhibits99: Chart on India - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on India - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits106: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits107: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity By Geographical Landscape ($ billion); Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: Almac Group Ltd. - Overview; Exhibits118: Almac Group Ltd. - Product / Service; Exhibits119: Almac Group Ltd. - Key offerings; Exhibits120: Boehringer Ingelheim International GmbH - Overview; Exhibits121: Boehringer Ingelheim International GmbH - Product / Service; Exhibits122: Boehringer Ingelheim International GmbH - Key news; Exhibits123: Boehringer Ingelheim International GmbH - Key offerings; Exhibits124: Cadila Pharmaceuticals Ltd. - Overview; Exhibits125: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibits126: Cadila Pharmaceuticals Ltd. - Key offerings; Exhibits127: Charles River Laboratories International Inc. - Overview; Exhibits128: Charles River Laboratories International Inc. - Business segments; Exhibits129: Charles River Laboratories International Inc. - Key offerings; Exhibits130: Charles River Laboratories International Inc. - Segment focus; Exhibits131: Cmic Holdings Co. Ltd - Overview; Exhibits132: Cmic Holdings Co. Ltd - Business segments; Exhibits133: Cmic Holdings Co. Ltd - Key offerings; Exhibits134: Cmic Holdings Co. Ltd - Segment focus; Exhibits135: Dr Reddys Laboratories Ltd. - Overview; Exhibits136: Dr Reddys Laboratories Ltd. - Business segments; Exhibits137: Dr Reddys Laboratories Ltd. - Key news; Exhibits138: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits139: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits140: Laboratory Corp. of America Holdings - Overview; Exhibits141: Laboratory Corp. of America Holdings - Business segments; Exhibits142: Laboratory Corp. of America Holdings - Key news; Exhibits143: Laboratory Corp. of America Holdings - Key offerings; Exhibits144: Laboratory Corp. of America Holdings - Segment focus; Exhibits145: Lonza Group Ltd. - Overview; Exhibits146: Lonza Group Ltd. - Business segments; Exhibits147: Lonza Group Ltd. - Key news; Exhibits148: Lonza Group Ltd. - Key offerings; Exhibits149: Lonza Group Ltd. - Segment focus; Exhibits150: Lupin Ltd. - Overview; Exhibits151: Lupin Ltd. - Business segments; Exhibits152: Lupin Ltd. - Key news; Exhibits153: Lupin Ltd. - Key offerings; Exhibits154: Lupin Ltd. - Segment focus; Exhibits155: OPTIMAPHARM d.o.o. - Overview; Exhibits156: OPTIMAPHARM d.o.o. - Product / Service; Exhibits157: OPTIMAPHARM d.o.o. - Key offerings; Exhibits158: Parexel International Corp. - Overview; Exhibits159: Parexel International Corp. - Product / Service; Exhibits160: Parexel International Corp. - Key offerings; Exhibits161: PCI Pharma Services - Overview; Exhibits162: PCI Pharma Services - Product / Service; Exhibits163: PCI Pharma Services - Key offerings; Exhibits164: Recipharm AB - Overview; Exhibits165: Recipharm AB - Business segments; Exhibits166: Recipharm AB - Key offerings; Exhibits167: Recipharm AB - Segment focus; Exhibits168: Syneos Health Inc. - Overview; Exhibits169: Syneos Health Inc. - Product / Service; Exhibits170: Syneos Health Inc. - Key offerings; Exhibits171: Thermo Fisher Scientific Inc. - Overview; Exhibits172: Thermo Fisher Scientific Inc. - Business segments; Exhibits173: Thermo Fisher Scientific Inc. - Key news; Exhibits174: Thermo Fisher Scientific Inc. - Key offerings; Exhibits175: Thermo Fisher Scientific Inc. - Segment focus; Exhibits176: Inclusions checklist; Exhibits177: Exclusions checklist; Exhibits178: Currency conversion rates for US$; Exhibits179: Research methodology; Exhibits180: Information sources; Exhibits181: Data validation; Exhibits182: Validation techniques employed for market sizing; Exhibits183: Data synthesis; Exhibits184: 360 degree market analysis; Exhibits185: List of abbreviations